What's New in Critical Illness and Injury Science? Mortality effects of tocilizumab for patients admitted with COVID-19 pneumonia

Detalles Bibliográficos
Autores principales: Miller, Andrew C., D’Silva, Yannick A., Gruber, Eric A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer - Medknow 2021
Materias:
Editorial
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8318164/
https://www.ncbi.nlm.nih.gov/pubmed/34395203
http://dx.doi.org/10.4103/ijciis.ijciis_52_21

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8318164/
https://www.ncbi.nlm.nih.gov/pubmed/34395203
http://dx.doi.org/10.4103/ijciis.ijciis_52_21

Ejemplares similares